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Abstract
Background: Type A1 Clostridium botulinum strains are a group of Gram-positive, spore-forming anaerobic bacteria
that produce a genetically, biochemically, and biophysically indistinguishable 150 kD protein that causes botulism.
The genomes of three type A1 C. botulinum strains have been sequenced and show a high degree of synteny. The
purpose of this study was to characterize differences among these genomes and compare these differentiating
features with two additional unsequenced strains used in previous studies.
Results: Several strategies were deployed in this report. First, University of Massachusetts Dartmouth laboratory Hall
strain (UMASS strain) neurotoxin gene was amplified by PCR and sequenced; its sequence was aligned with the
published ATCC 3502 Sanger Institute Hall strain and Allergan Hall strain neurotoxin gene regions. Sequence
alignment showed that there was a synonymous single nucleotide polymorphism (SNP) in the region encoding
the heavy chain between Allergan strain and ATCC 3502 and UMASS strains. Second, comparative genomic
hybridization (CGH) demonstrated that the UMASS strain and a strain expected to be derived from ATCC 3502 in
the Centers for Disease Control and Prevention (CDC) laboratory (ATCC 3502*) differed in gene content compared
to the ATCC 3502 genome sequence published by the Sanger Institute. Third, alignment of the three sequenced C.
botulinum type A1 strain genomes revealed the presence of four comparable blocks. Strains ATCC 3502 and ATCC
19397 share the same genome organization, while the organization of the blocks in strain Hall were switched.
Lastly, PCR was designed to identify UMASS and ATCC 3502* strain genome organizations. The PCR results
indicated that UMASS strain belonged to Hall type and ATCC 3502* strain was identical to ATCC 3502 (Sanger
Institute) type.
Conclusions: Taken together, C. botulinum type A1 strains including Sanger Institute ATCC 3502, ATCC 3502*,
ATCC 19397, Hall, Allergan, and UMASS strains demonstrate differences at the level of the neurotoxin gene
sequence, in gene content, and in genome arrangement.
Background
Clostridium botulinum is a Gram-positive, spore-form-
ing anaerobic bacterium that causes the severe neuro-
paralytic illness in humans and animals known as
botulism. There are seven serologically distinct types of
botulinum neurotoxin -types A, B, C, D, E, F, and G.
Comparison of 16 S rRNA sequences [1] showed that C.
botulinum strains forms four distinct clusters that corre-
spond to four physiological groups (I-IV), which sup-
ported the historical classification scheme based upon
biochemical and biophysical parameters. Group I (pro-
teolytic C. botulinum) strains produce one or sometimes
two toxins of type A, B or F; Group II (non-proteolytic
C. botulinum) strains produce toxins of type B, E, or F;
Group III strains produce toxins of type C or D; and
Group IV strains produce toxin of type G [2,3]. Further-
more, the toxinotypes are divided into many subtypes,
which have been defined as toxin sequences differing by
at least 2.6% identity at amino acid level [4]. Botulinum
type A neurotoxins are divided into five subtypes
termed A1, A2, A3, A4, and more recently to A5 [5];
botulinum type B neurotoxins are divided into five sub-
types termed B1, B2, B3, bivalent B, and non-proteolytic
botulinum B neurotoxin; botulinum type E neurotoxins
are classified into six subtypes: E1, E2, E3, E4, E5, and
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into F1 through F7 subtypes [7]. There are no known
subtypes from types C, D, and G [8].
The strains of C. botulinum used for the production of
type A therapeutic toxin (recently referred to as botuli-
num neuromedicine or BoNEM; Singh, 2009) are likely
to originate from those isolated and preserved by Ivan
C. Hall in the early 1900s. These strains, which include
include several type A strains from botulism cases in the
western United States [9] and both type A and B strains
from isolated wounds [10], were distributed to colleges
a n du n i v e r s i t i e st h r o u g h o u tt h ew o r l da n dd e p o s i t e di n
various culture collections [11,12]. As a result, many sub-
cultures were performed, and the strains designated as
“Hall” strains may not be identical to or may differ from
the original isolates as a result of long term passage.
In this communication, the genetic diversity of
C. botulinum was further explored by comparing the
genomic differences among several C. botulinum strains
including Sanger Institute ATCC 3502 [Hall 174, Gen-
Bank: AM412317], CDC ATCC 3502 (ATCC 3502*),
ATCC 19397 [GenBank: CP000726], Hall [GenBank:
CP000727], Allergan, and University of Massachusetts
Dartmouth laboratory Hall strain (UMASS strain), all
belonging to subtype A1. The results indicated that
genetic diversity existed among these subtype A1 strains
including those designated simply as “Hall”.
Results
C. botulinum A1 neurotoxin gene complex
The C. botulinum type A1 neurotoxin complex genomic
cluster spans 11719 bp in ATCC 3502 [GenBank:
AM412317, positions 901881 through 913599]. The
identical genomic cluster was also found in four other
genome sequences, whose GenBank accession numbers
are CP000727 (C. botulinum A strain Hall), CP000726
(C. botulinum A strain ATCC 19397), DQ409059 (Hall
A BoNT/A cluster), and AF461540 (Hall A-hyper
BoNT/A cluster and its flanking regions).
The botulinum type A1 neurotoxin complex consists of
six genes, namely, ha70, ha17, ha33, botR, ntnh,a n dbont/
A, whose coding regions in aggregate consist of 11215 bp
out of 11719 bp botulinum A neurotoxin genomic cluster
(Sanger Institute ATCC 3502). Sequence alignment of this
cluster with each individual gene sequence [GenBank:
AF488745-AF488750] from the Allergan Hall strain [13]
revealed that only two base pairs were different: one was
in the region encoding the heavy chain of neurotoxin
botulinum type A1, the other was in botR region (position
9 in AF488750, data not shown). Both are synonymous
single nucleotide polymorphisms (SNP), which are not
predicted to result in an amino acid change.
The botulinum neurotoxin type A1 gene (bont/A)
from the UMASS strain was also sequenced and
compared to that of ATCC 3502 and Allergan Hall
strains. The UMASS sequence was identical to ATCC
3502 but different from Allergan Hall strain by one base
pair (position 3591 of the neurotoxin gene, data not
shown). We did not sequence the botR region in
UMASS strain, therefore, it is unclear whether the SNP
in botR region exists or not.
Comparative genomic hybridization of UMASS strain
The comparative genomic hybridization (CGH) microar-
ray featured overlapping probes covering the entire
C. botulinum A1 strain ATCC 3502 genome sequence
[GenBank: AM412317]. The ATCC 3502* strain was
used as reference and the UMASS strain as test strain.
The hybridization results indicated the presence of sev-
eral regions that were different between UMASS strain
and Sanger Institute ATCC 3502 strain (Figure 1 and Fig-
ure 2), and, in some cases, were even different between
ATCC 3502* and Sanger Institute ATCC 3502 strain
( F i g u r e2 ) .T h en a t u r eo ft h ed e l e t e ds e q u e n c e( 2 7 4 0 9
bp) in Figure 1 is unclear. The same block sequence was
also found in ATCC 19397 genome but not in Hall strain
genome, as retrieved through NCBI Blast server.
Genome organizations of C. botulinum A1 strains
As mentioned above, three fully sequenced C. botulinum
A1 strain genomes are deposited in GenBank: ATCC
3502, ATCC 19397, and Hall. Mauve software [14] was
used to compare and analyze the organization of these
genomes. At the gross level, based on the ATCC 3502
genome organization, all three genomes were divided into
four blocks: blocks 1, 2, 3, and 4, sequentially (Figure 3).
The three genomes were divided into two organiza-
tional patterns. ATCC 3502 and ATCC 19397 share the
same pattern, while the positions of block 2 and block 3
were translocated in Hall, suggesting a genomic rearran-
gement event may have occurred among these strains.
Moreover, within the same pattern and between gen-
omes of ATCC 3502 and ATCC 19397, many regions
inside the comparable blocks were different, as shown in
areas that are completely white in Figure 3. Interestingly,
two such regions (positions 1822680 through 1864850
and positions 2466354 through 2523055) in the ATCC
3502 genome are prophages that are absent in two
other fully sequenced C. botulinum A1 strains: Hall and
ATCC 19397 (data retrieved through NCBI Blast ser-
ver). These observations are in agreement with previous
reports [3,5] and also confirmed by our CGH findings
(data not shown).
Characterization of the ATCC 3502* and UMASS Hall
strain genome organizational patterns
To characterize whether the genome organizational pat-
tern of ATCC 3502* and UMASS Hall strain fits into
Fang et al. BMC Genomics 2010, 11:725
http://www.biomedcentral.com/1471-2164/11/725
Page 2 of 8either of above two patterns, a PCR strategy was utilized.
Primers were designed to span the boundary between
block 3 and block 4 for the ATCC 3502 and ATCC
19397 pattern or between block 3 and block 2 for the
Hall pattern (Figure 4). In one set of PCR reactions,
using ATCC 3502* genomic DNA as template, the
expected PCR product was generated from every PCR
reaction with different combinations of upstream and
downstream primers for ATCC 3502 and ATCC 19397
pattern (Figure 5 Panel A, lanes 1 to 4) but not from
Normalized Ratio
UMASS Strain 
Raw Signal Intensity
ATCC 3502* Strain 
Raw Signal Intensity
2379161 (CBO2220)  2351753 (CBO2200)
ATCC 3502 
Genome Positions 
Figure 1 Absence of CBO2200-CBO2220 in the UMASS strain. The number above tracks indicates the absence region in the ATCC 3502
genome location and its corresponding Coding Sequence (CDS) location, expressed as CBO number; the middle track is the UMASS strain raw
signal intensity; and the bottom track is the ATCC 3502* reference strain raw signal intensity. The top track is normalized log2 ratios of the
fluorescence intensity of the reference strain/test strain. UMASS strain genome fragment corresponding to ATCC 3502 genome region from
2351753 (the start of CBO2200) to 2379161 (the end of CBO2220) is absent.
Normalized Ratio
UMASS Strain 
Raw Signal Intensity
ATCC 3502* Strain 
Raw Signal Intensity
1266209 (CBO1152)  1262612 (CBO1149)
ATCC 3502 
Genome Positions 
Figure 2 Absence of CBO1149-CBO1152 in both UMASS and ATCC 3502* strains. Tracks are laid out as those in Figure 1. Both UMASS
strain and ATCC 3502* genome fragment corresponding to ATCC 3502 genome region from position 1262612 (the start of CBO1149) to position
1266209 (the end of CBO1152) are absent.
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Page 3 of 8those with different combination of primers for Hall pat-
tern reactions (data not shown). These results demon-
s t r a t e dt h a tt h eg e n o m i co r g a n i z a t i o no fA T C C3 5 0 2 *
indeed was identical to the ATCC 3502 Sanger Institute
and ATCC 19397 strain genome organizations.
In the other set of PCR reactions, using UMASS strain
genomic DNA as template, none of the PCR reactions
containing one of four different primer combinations
generated a product for ATCC 3502 and ATCC 19397
pattern (data not shown); however, every PCR reaction
containing one of four different primer combinations
amplified the predictable size of PCR products for Hall
pattern (Figure 5 Panel B, lanes 5 to 8). The largest PCR
product derived from PCR reaction with upstream pri-
mer (Puo) and downstream primer (P2do) combination
and using UMASS strain genomic DNA as template was
cloned and sequenced. The sequence from this product
was 100% identical to the corresponding region in the
Hall strain genome, confirming that the genomic organi-
zation of UMASS strain belonged to Hall type.
Analysis of the region containing the sequenced PCR
product demonstrated that the region is further divided
into F1 fragment (167 bp) that is located in 3’-end of
block 3 of Hall strain genome and F2 fragment (587 bp)
that is located in 5’-end of block 2 of Hall strain gen-
ome. As shown in Figure 6, the F1 and F2 fragments, a
continuous region in Hall strain genome, were split into
two separate fragments in ATCC 3502 and ATCC
19397 strain genomes, although each remained within
their individual rearranged blocks.
Further analysis of block 3 (20728 bp in strain ATCC
3502) revealed that virtually identical sequences are
found in strain ATCC 19397 (20726 identities out of
20728 bp) and strain Hall (20710 identities out of 20714
bp). The GC content (27.3%) of block 3 in strain ATCC
3502 is not significantly different from 28.2% of whole
genome GC content for each sequenced subtype A1
strain genome. Within block 3, we identified two 314 bp
inverted repeat sequences (93% identities, Figure 7) that
are located before the first gene in the block (CBO0526)
and after the last gene in the block (CBO0542). Notably,
no genes encoding a transposase or a direct repeat
sequence (characteristic of transposon mobile element)
was found in the region. In addition, the downstream
inverted repeat has no overlapping sequence with F1
fragment mentioned above.
12 3 4
12 3 4
12 34
ATCC 3502
ATCC 19397
Hall
Figure 3 C. botulinum ATCC 3502, ATCC 19397, and Hall strains genome alignment. The alignment display is organized into one horizontal
“panel” per input genome sequence. Each genome’s panel contains the name of the genome sequence, a scale showing the sequence
coordinates for that genome, and a single black horizontal center line. All the blocks lie above the center line, which indicates that the aligned
regions are in the forward orientation relative to the first genome sequence. Colored blocks in the first genome are connected by lines to
similarly colored blocks in the second and third genomes. These lines indicate which regions in each genome are homologous and internally
free from genomic rearrangement. There are only four blocks (1 to 4) from each genome. ATCC 3502 (top panel) and ATCC 19397 (middle
panel) have the same block arrangements, while, in Hall (bottom panel), the positions of blocks 2 and 3 are switched. Inside each block, areas
that are completely white were not aligned and contain sequence elements specific to a particular genome. Numbers in white inside the blocks
indicate the block numbers.
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Genetic diversity has been described in other pathogenic
bacterial species [15]. In one study, 73 C. difficile strains
isolated from different resources were analyzed by CGH
with microarrays containing coding sequences from C.
difficile strains 630 and QCD-32g58. Startlingly, only
about 16% of the genes in strain 630 were highly con-
served among all strains [16]. In another study, compari-
son of the laboratory strain Escherichia coli K12 to both
uropathogenic and enterohemorrhagic strains revealed
that less than 40% of the total number of genes present
were shared by these three strains [17]. Quite recently,
CGH was performed on a relatively large scale to com-
pare 61 strains of proteolytic C. botulinum and C. sporo-
genes using ATCC 3502 as reference strain [5].
Approximately 63% of the coding sequences (CDSs) pre-
sent in reference strain ATCC 3502 were common to all
61 strains. Even within the toxin gene cluster, a typically
conserved region, the gene arrangement could be differ-
ent between different serotypes or subtypes of the same
serotype [18,19]. The differences in the genome organi-
zation of the ATCC 3502* strain and ATCC 3502 (San-
ger Institute), as shown in this report, further
substantiated the dynamic nature of botulinum strain
genome.
Lateral (or horizontal) gene transfer, through transfor-
mation, transduction, and conjugation, is a major
mechanism for the generation of genetic diversity in
pathogenic bacteria [20,21]. In C. botulinum, the neuro-
toxin cluster has been shown to be present within plas-
mids or on the chromosome in strains of the same or
different serotypes, which is consistent with horizontal
gene transfer [1]. None of the subtype A1 strains, whose
genomes were sequenced, harbor the toxin gene on a
plasmid. One plasmid, pBOT3502, existing in the ATCC
3502 Sanger Institute strain, was not found in the
ATCC 19397 and Hall strains [3,5] and, even more
strikingly, not in the ATCC 3502* strain genome
sequences [18]. Further work is required to determine
whether and if so, at what rate, loss of this plasmid
occurs during laboratory passage.
The subtype A1 strain genetic diversity was also evi-
denced by the different location of genome block 3
when strains ATCC 3502 and ATCC 19397 are com-
pared with strain Hall. Although this 20728 bp block
contained two inverted repeat sequence fragments, we
were unable to find direct repeat sequences or any gene
that encodes a transposase. Therefore, we are unable to
ascribe the genomic block switch observed in this study
to a transposon-related mobile element mechanism
P4do
4
2
4 ATCC 3502
ATCC 19397
Hall
614844  P4di 
641192  P4di 
468268   P2di 
640868 
467966 
614520 
Puo
Puo
Puo
3
3
3 468055  Pui
614609  Pui
640957  Pui 641481
468704 
615133  P4do
P2do
Figure 4 Primers designed to characterize the genome organizational patterns of ATCC 3502* and UMASS strains.T h i si sp a r to f
exploded view of figure 3 on which the primer design is based. This region spans the boundary between block 3 and 4 (ATCC 3502 and ATCC
19397) and the boundary between block 3 and 2 (Hall). Puo, upstream outside primers; Pui, upstream inside primers; P4di, downstream inside
primers for block 4; P4do, downstream outside primers for block 4; P2di, downstream inside primers for block 2, and P2do, downstream outside
primers for block 2. Arrows with numbers in red indicate the starting (upstream primer) or ending (downstream primers) positions in each
genome. Numbers in white inside the blocks indicate the block numbers.
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650 bp
500 bp
200 bp
300 bp
750 bp
500 bp
250 bp
AB
Puo
P4di
Pui
P4do
Pui
P4di
Puo
P2do
Puo
P2di
Pui
P2do
Pui
P2di
Upstream Primers
Downstream Primers
Expected Size (bp)
Puo
P4do
614 325 525 236 739 303 650 214
Figure 5 Identification of the genome organizational patterns of ATCC 3502* and UMASS strains by PCR.P a n e lA( l a n e s1t h r o u g h4 ) ,
PCR products from ATCC 3502* strain genomic DNA amplifications. Panel B (lanes 5 through 8), PCR products from UMASS strain genomic DNA
amplifications.
ATCC 3502
ATCC 19397
Hall
1
1
1
3
3
3
2
2
2
4
4
F1
F1
F1
F2
F2
F2
Figure 6 PCR fragment distributions in C. botulinum type A1 strain genomes. This is part of exploded view of figure 3. PCR product from
Hall strain primers Puo and P2do combination was divided into two fragments: F1 (bright red) and F2 (bright green). F1 and F2 fragments were
split in ATCC 3502 and ATCC 19397 genomes but remained within comparable blocks.
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Page 6 of 8[22-24]. Whether such differences in genomic arrange-
ment among the subtype A1 strains examined has an
effect on botulinum neurotoxin production remains to
be elucidated.
In this report, the botulinum type A1 neurotoxin com-
plex gene sequences of several strains were compared.
There are at least five neurotoxin complex clusters from
C. botulinum type A1 strains which have been fully
sequenced and deposited into public databases. Sequence
analysis showed that the sequences of five fully
sequenced neurotoxin complex clusters were identical,
and their gene coding regions and toxin gene complex
from Allergan Hall strain displayed two synonymous sin-
gle nucleotide polymorphisms: one is in the region
encoding toxin heavy chain, the other in botR.T h e s e
findings are quite different from those in an earlier report
which showed that there were 93%, 94%, and 97% identi-
ties in the genes ntnh, botR,a n dha70 at amino acid
level, respectively [13]. The apparent discrepancy of these
findings is likely due to different versions of genomic
sequence that were used: version 16-Apr-2002 (GenBank
accession number is unclear) of ATCC 3502 Hall strain
was used in Allergan’s report, while version 21-Nov-2006
(AM412317, which is one of the live versions) of ATCC
3502 Hall strain was used in this report.
Conclusions
In summary, genetic diversity exists among the botuli-
num subtype A1 strains examined in this study. The
neurotoxin gene of the UMASS strain exhibited the
same nucleotide sequence as that of other published
subtype A1 strains, except for the Allergan Hall strain.
At the whole genome level, UMASS strain, ATCC3502*,
and Sanger Institute 3502 strains, ATCC 19397, and
Hall demonstrated differences in both gene content and
genome arrangement.
Methods
Growth of bacterial strains
C. botulinum strains were grown anaerobically at 37°C
in Trypticase-peptone-glucose-yeast extract (TPGY)
medium. Stock cultures were stored in bovine brain
medium at 4°C.
Cloning and sequencing UMASS strain botulinum A1
toxin gene
PCR primers were designed to amplify the C. botulinum
type A1 neurotoxin gene from UMASS strain. The PCR
product was cloned and sequenced. The UMASS botuli-
num A1 neurotoxin nucleotide sequence, its counterpart
regions in the Allergan Hall strain [13] and ATCC 3502
strain [GenBank: AM412317] were aligned by using EBI
ClustalW2 http://www.ebi.ac.uk/Tools/clustalw2/index.
html.
Comparative genomic hybridization
Genomic DNA extraction was performed as described
previously [18]. A custom C. botulinum type A1 strain
ATCC 3502 comparative genomic hybridization arrays
was used as described previously [18]. Genomic DNA
from the UMASS test strain was labeled with Cy3 ran-
dom primers and the reference strain, ATCC 3502*, was
labeled with Cy5. The data were visualized with Signal-
Map version 1.9 (Nimblegen, Madison, WI) and are pre-
sented as normalized log2 ratios of the fluorescence
intensity of the reference strain/test strain. The CGH
microarray data were deposited in the NCBI Gene
Expression Omnibus (GEO) [Accession: GSE21241]
Whole genome comparison of C. botulinum A1 stains
Multiple genome alignments were performed by using
Mauve [14]. Specifically, we analyzed the genome
sequences of C. botulinum type A str. ATCC 3502 com-
plete genome [GenBank: AM412317]; C. botulinum type
A str. ATCC 19397 complete genome [GenBank:
CP000726]; and C. botulinum type A str. Hall complete
genome [GenBank: CP000727].
Identification of ATCC 3502* and UMASS strain genome
organizational patterns
Based on the genome organizational patterns observed
by multiple genome alignment, PCR primers were
620321 641048 
Block 3
CBO0525
Block 2 Block 4
621120 640397
314 bp 314 bp
640397 640710  621117  620804 
CBO0526 CBO0542 CBO0543 F1
Figure 7 Schematic representation of sequence elements of strain ATCC3502 genome block 3 and its flanking regions. ATCC3502
genome block 3 spans the region between CBO0525 (the end of block 2) and CBO0543 (the start of block 4) and is 20728 bp in length. The
vertical red lines indicate the block boundaries; the boxes in blue indicate annotated coding regions; the boxes in green indicate inverted repeat
sequences; and the F1 fragment is indicated by a red box.
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Page 7 of 8designed in the way that the expected PCR fragment
will span the boundaries between the rearranged block 3
(ATCC 3502 block number) and its surrounding blocks
2 and 4 for both patterns. The common upstream pri-
mers, which are inside the rearranged block 3, are 5’-
GAA GGC CTC CGG TGG CGA TAT C-3’ (outsider
primers, Puo) and 5’-GTG TAG AGA ATC GAA ACA
AAA TCA TCC ACA TC-3’ (inside primer, Pui). The
downstream primers inside the block 4 of ATCC 3502
and ATCC 19397 are 5’-CTT GAA TGG CTT GGC
ATA TTA AGT GGG-3’ (inside primer, P4di) and 5’-
AGT TGG CTT TAT AAT CCC TTG GAT TTC
AGG-3’ (outsider primers, P4do). The downstream pri-
mers inside block 2 of Hall are 5’-CAG AAT TAG CAG
ACA GAC TAC TTT CTA CC-3’ (inside primer, P2di)
and 5’-ATA GCC TTA TTT GGA GGC GGT CAG G-
3’ (outsider primers, P2do). Eight PCR reactions con-
taining different upstream and downstream primer com-
binations were set up using genomic DNA isolated from
either ATCC 3502* strain or UMASS strain. The PCR
product amplified with primers Puo and P2do from the
UMASS strain was cloned into pCR4-TOPO (Invitrogen,
Carlsbad, CA) and sequenced, and the sequencing
results were used to search the GenBank database.
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